does select health cover glp 1 How to Find a Plan That Covers GLP-1 Medications Like Wegovy & Ozempic Medicare to cover GLP-1 weight

What is Retatrutide

2026: Acceleration and Market Transformation The coming year promises rapid evolution across innovation, policy, and market access

Background In idiopathic intracranial hypertension (IIH), sustained weight loss is the main pillar in modifying disease course, whereby glucagon-like peptide-1 receptor agonists (GLP-1-RAs) could present an attractive treatment option

At the same time, payer policies often require discontinuation of GLP-1 therapy when a patients BMI drops below a set threshold, inadvertently triggering a frustrating cycle of weight loss and regainthe so-called yo-yo effect. This not only impacts ongoing adherence and persistence but also undermines the long-term cost-effectiveness of these therapies for healthcare systems